- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03990792
Personalized Prevention of Depression in Primary Care
Preventing the Onset of Depression Through a Personalized Intervention Based on ICTs, Risk Prediction Algorithms and Decision Support Systems for Patients and GPs: the e-predictD Study
The main goal is to design, develop and evaluate a personalized intervention to prevent the onset of depression based on Information and Communications Technology (ICTs), risk predictive algorithms and decision support systems (DSS) for patients and general practitioners (GPs). The specific goals are 1) to design and develop a DSS, called e-predictD-DSS, to elaborate personalized plans to prevent depression; 2) to design and develop an ICT solution that integrates the DSS on the web, a mobile application (App), the risk predictive algorithm, different intervention modules and a monitoring-feedback system; 3) to evaluate the usability and adherence of primary care patients and their GPs with the e-predictD intervention; 4) to evaluate the effectiveness of the e-predictD intervention to reduce the incidence of major depression, depression and anxiety symptoms and the probability of major depression next year; 5) to evaluate the cost-effectiveness and cost-utility of the e-predictD intervention to prevent depression.
Methods: This is a randomized controlled trial with allocation by cluster (GPs), simple blind, two parallel arms (e-predictD vs "active m-Health control") and 1 year follow-up including 720 patients (360 in each arm) and 72 GPs (36 in each arm). Patients will be free of major depression at baseline and aged between 18 and 55 years old. Primary outcome will be the incidence of major depression at 12 months measured by CIDI. As secondary outcomes: depressive and anxiety symptomatology measured by PHQ-9 and GAD-7 and the risk probability of depression measured by predictD algorithm, as well as cost-effectiveness and cost-utility. The e-predictD intervention is multi-component and it is based on a DSS that helps the patients to elaborate their own personalized depression prevention plans, which the patient approves, and implements, and the system monitors offering feedback to the patient and to the GPs. It is an e-Health intervention because it is based on a web and m-Health because it is also implemented on the patient's smartphones through an App. In addition, it integrates a risk algorithm of depression, which is already validated (the predictD algorithm). It also includes an initial GP-patient interview and a specific training for the GP. Finally, a map of potentially useful local community resources to prevent depression will be integrated into the DSS.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Barcelona, Spain
- Juan M. Mendive
-
Jaén, Spain
- María Isabel Ballesta Rodríguez
-
Linares, Spain
- Antonina Rodríguez Bayón
-
Málaga, Spain
- Juan Á Bellón
-
Salamanca, Spain
- Emiliano Rodríguez
-
Zaragoza, Spain
- Yolanda López del Hoyo
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- PHQ-9 <10 at baseline
- Moderate-high risk of depression (predictD risk algorithm score ≥ 10%)
Exclusion Criteria:
- Not have a smartphone and internet for personal use
- Unable to speak Spanish
- Documented terminal illness
- Documented cognitive impairment
- Limiting sensory disorder (e.g. deafness)
- Documented serious mental illness (psychosis, bipolar, addictions, etc.)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: e-predictD intervention
In this arm, patients will receive a personalized intervention to prevent depression based on ICTs, risk predictive algorithms and decision support systems (DSS) for patients and General Practitioners (GPs).
|
The intervention is based on validated risk algorithms to predict depression and includes: 1) Mobile applications as main user's interface; 2) a DSS that helps patients to develop their own personalized plans to prevent (PPP) depression; 3) eight intervention modules (the core of the system) including activities to prevent depression, to be proposed by the DSS and chosen by the patient.
The intervention is biopsychosocial and multi-component, including the following modules: physical exercise, improving sleep, expanding relationships, problem solving, improving communication skills, assertiveness training, making decisions and managing thoughts.
Patients will implement the recommendations and the tool will monitor these actions, offering feedback to improve their PPP at 3, 6 and 9 months.
The intervention also includes an initial and single 15-minute face-to-face GP-patient interview.
|
Active Comparator: m-Health control
In this arm, patients will continue receiving the usual care from their GPs.
In addition, they will use an App with the same appearance as the e-predictD App but it will only send weekly messages about physical and mental health management.
This intervention is not personalized and does not include GP training and GP-patient interview.
|
The intervention consists of an App that weekly send brief psychoeducational messages about physical and mental health (depression, anxiety, sleep hygiene, physical activity, etc.)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of major depression measured by the Composite International Diagnostic Interview (CIDI)
Time Frame: 12 months
|
Composite International Diagnostic Interview (CIDI) is a structured diagnostic interview that provides current diagnoses of major depression
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Depressive symptoms measured by the Patient Health Questionnaire-9 (PHQ-9)
Time Frame: 12 months
|
The Patient Health Questionnaire-9 (PHQ-9) measures symptoms of depression through 9 items, each of which is scored 0 ('not at all') to 3 ('nearly every day').
Low scores are equivalent to less symptoms of depression, the scale range is 0 to 27 (9 items)
|
12 months
|
Anxious symptoms measured by the General Anxiety Questionnaire (GAD-7)
Time Frame: 12 months
|
The General Anxiety Questionnaire (GAD-7) measures generalized anxiety disorder through 7 items, each of which is scored 0 ('not at all') to 3 ('nearly every day').
Low scores are equivalent to less symptoms of anxiety, the scale range is 0 to 21 (7 items)
|
12 months
|
Probability of depression (predictD risk algorithm)
Time Frame: 12 months
|
12 months
|
|
Cost-effectiveness and cost-utility
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PI15/00401
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Lawson Health Research InstituteTerminated
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
Clinical Trials on e-predictD intervention
-
The Mediterranean Institute for the Advance of...Preventive Services and Health Promotion Research Network; University of Malaga and other collaboratorsActive, not recruiting
-
Monash UniversityCompletedDiabetes Mellitus, Type 2 | Intervention Studies | BehaviorMalaysia
-
Hong Kong Baptist UniversityGuangdong Provincial People's HospitalCompletedPhysical Activity | Cardiac Rehabilitation | Fruit and Vegetable IntakeChina
-
Hong Kong Baptist UniversityCompletedPhysical Activity | Health Behavior | Healthy Diet
-
University of WashingtonCompletedPhysical Activity | Heart Arrest | Implantable Defibrillator UserUnited States
-
Hospital Israelita Albert EinsteinBeneficência Portuguesa de São PauloNot yet recruiting
-
VA Office of Research and DevelopmentEmory UniversityCompleted
-
Diakonhjemmet HospitalThe Norwegian Rheumatism AssociationActive, not recruiting
-
University of Southern DenmarkRecruitingMultiple SclerosisDenmark
-
Chinese University of Hong KongCompletedCardiovascular DiseaseHong Kong